Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study
Open Access
- 26 May 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (5)
- https://doi.org/10.1042/bsr20194192
Abstract
Bladder cancer is the 11th most common cancer in the world. Bladder cancer can be roughly divided into muscle invasive bladder cancer (MIBC) and non-muscle invasive bladder cancer (NMIBC). The aim of the present study was to identify the key genes and pathways associated with the progression of NMIBC to MIBC and to further analyze its molecular mechanism and prognostic significance. We analyzed microarray data of NMIBC and MIBC gene expression datasets (GSE31684) listed in the Gene Expression Omnibus (GEO) database. After the dataset was analyzed using R software, differentially expressed genes (DEGs) of NMIBC and MIBC were identified. These DEGs were analyzed using Gene Ontology (GO) enrichment, KOBAS-Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and protein–protein interaction (PPI) analysis. The effect of these hub genes on the survival of bladder cancer patients was analyzed in The Cancer Genome Atlas (TCGA) database. A total of 389 DEGs were obtained, of which 270 were up-regulated and 119 down-regulated. GO and KEGG pathway enrichment analysis revealed that DEGs were mainly involved in the pathway of protein digestion and absorption, extracellular matrix (ECM) receiver interaction, phantom, toll-like receptor (TLR) signaling pathway, focal adhesion, NF-κB signaling pathway, PI3K/Akt signaling pathway, and other signaling pathways. Top five hub genes COL1A2, COL3A1, COL5A1, POSTN, and COL12A1 may be involved in the development of MIBC. These results may provide us with a further understanding of the occurrence and development of MIBC, as well as new targets for the diagnosis and treatment of MIBC in the future.Keywords
This publication has 36 references indexed in Scilit:
- Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer riskMedical Oncology, 2013
- Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder CancerClinical Cancer Research, 2012
- The extracellular matrix: A dynamic niche in cancer progressionThe Journal of cell biology, 2012
- The bladder extracellular matrix. Part I: architecture, development and diseaseNature Reviews Urology, 2009
- Inactivation of p53 and Pten promotes invasive bladder cancerGenes & Development, 2009
- Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years LaterJournal of Urology, 2008
- Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cellsMolecular Cancer Therapeutics, 2007
- Collagen I Promotes Metastasis in Pancreatic Cancer by Activating c-Jun NH2-Terminal Kinase 1 and Up-regulating N-Cadherin ExpressionCancer Research, 2006
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004